Clinical trial
DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril
NCT00274118 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00274118 |
|---|---|
| Title | DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril |
| Official title | DETAIL = Diabetics Exposed to Telmisartan And enalapIL: A Randomised, Double-blind, Parallel-group Comparison of the Renal and Antihypertensive Effects of Telmisartan and Enalapril in Subjects With Mild to Moderate Hypertension and Concurrent Type II Diabetes Mellitus and Diabetic Nephropathy |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | telmisartan, enalapril |
| Enrollment | 250 |
| Start date | Jul 1, 1997 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Jan 10, 2006 |
| Last update posted | Nov 1, 2013 |
| Countries | Denmark, Finland, Netherlands, Norway, Sweden, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: